Danaher Corp.

DHR

$324.00

+63.2% (1 year change)

Daniel Loeb Holding value: $928 Million Chuck Akre Holding value: $536 Million Ray Dalio Holding value: $278 Million Ken Griffin Holding value: $207 Million Jim Simons Holding value: $160 Million Joel Greenblatt Holding value: $11.7 Million Mario Gabelli Holding value: $6.83 Million Tom Russo Holding value: $383 Thousand Jeremy Grantham Holding value: $0 Julian Robertson Holding value: $0 David Einhorn Holding value: $0 George Soros Holding value: $0

Market Cap

$234 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$200.87 - $333.29

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

43.04x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.78 (0.24%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $234 Billion
Enterprise Value $248 Billion
Dividend Yield $0.78 (0.24%)
1 Year Return +63.4%
52-Week High $333.29
52-Week Low $200.87
Beta 0.63
Outstanding Shares 714 Million
Avg 30 Day Volume 2.01 Million

Valuation

P/E Ratio 43.04
PEG 22.82
Earnings per Share $7.46
Price to Sales Ratio 9.53
Price to Book Ratio 5.79
Revenue to Enterprise Value 10.02
EBIT to Enterprise Value 44.91
Total Debt to Enterprise Value 0.08
Debt to Equity 0.5

Profitability

Revenue $24.8 Billion
Gross Profit $14.3 Billion
EBIT $5.53 Billion
Net Income $4.6 Billion
Profit Margin 18.53%
Quarterly Earnings Growth (YoY) +188.6%
Return on Equity 11.37%
Return on Assets 6.09%
Return on Invested Capital 8.06%

News

Pharmaceutical Filtration Market Remain Positive On Improving Demand Outlook: Danaher,GE Healthcare,Merck,Sartorius

Pharmaceutical Filtration Market Remain Positive On Improving Demand Outlook: Danaher,GE Healthcare,Merck,Sartorius

Global Pharmaceutical Filtration Market Report 2021, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation...

iCrowdNewswire iCrowdNewswire, 5 days ago
In-Vitro Diagnostics Market worth $96.0 billion by 2025 - Leading Key Players are Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US)

In-Vitro Diagnostics Market worth $96.0 billion by 2025 - Leading Key Players are Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US)

According to the new market research report "In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncol...

OpenPR OpenPR, 11 days ago
Danaher (DHR) Good points As Market Dips: What You Ought to Know

Danaher (DHR) Good points As Market Dips: What You Ought to Know

Danaher (DHR) closed at $332.43 within the newest buying and selling session, marking a +0.3% transfer from the prior day. This alteration outpaced the S&P 500s 0.03% loss on the day. Heading into ...

FXNews24 FXNews24, 14 days ago
To improve your user experience we use cookies.